V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20157836 | 20060329 | 1.55 | 36.8 | Adjuvant (A) | 2016-01-28 | 2016-02-04 | ECX | 02 | N | ECX | 101642608 |
| 20157837 | 20060330 | 1.77 | 74 | Adjuvant (A) | 2018-07-16 | 2018-08-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100499940 |
| 20157843 | 20060331 | 1.53 | 99.5 | Neo-adjuvant (N) | 2018-08-01 | 2018-08-19 | ECX | N | null | ECX | 101318526 |
| 20157844 | 20060332 | 1.67 | 81.15 | Curative (C) | 2017-12-14 | 2017-12-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100452814 |
| 20157846 | 20060333 | 1.71 | 95.4 | Neo-adjuvant (N) | 2016-03-16 | 2016-03-26 | ECX | 02 | N | ECX | 101017982 |
| 20157847 | 20060334 | 1.67 | 68.4 | Palliative (P) | 2019-06-07 | 2019-06-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100628074 |
| 20157849 | 20060335 | null | null | Palliative (P) | 2017-06-30 | 2017-07-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100050845 |
| 20157850 | 20060336 | 1.68 | 67.35 | Neo-adjuvant (N) | 2016-06-09 | 2016-06-30 | ECX | 02 | N | ECX | 100908531 |
| 20157852 | 20060337 | 1.82 | 71 | Palliative (P) | 2016-04-26 | 2016-04-27 | ECX | 02 | N | ECX | 101590738 |
| 20157853 | 20060338 | 1.51 | 51.2 | Palliative (P) | 2018-04-03 | 2018-04-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100257954 |
| 20157854 | 20060339 | 1.6 | 53.3 | Palliative (P) | 2020-03-05 | 2020-03-16 | Gemcitabine + Capecitabine | N | N | ECX | 101208682 |
| 20157855 | 20060340 | 1.52 | 72 | Adjuvant (A) | 2018-08-22 | 2018-09-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101054926 |
| 20157856 | 20060341 | 1.57 | 51.7 | Palliative (P) | 2016-03-03 | 2016-03-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101040590 |
| 20157857 | 20060342 | 1.54 | 104 | Palliative (P) | 2017-12-08 | 2017-12-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101043003 |
| 20157861 | 20060343 | 1.8 | 72 | Adjuvant (A) | 2017-12-21 | 2017-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100097029 |
| 20157862 | 20060344 | 1.62 | 66.3 | Neo-adjuvant (N) | 2016-12-24 | 2017-01-06 | ECX | N | N | ECX | 101028937 |
| 20157868 | 20060345 | 1.86 | 81 | Adjuvant (A) | 2020-07-28 | 2020-07-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100581466 |
| 20157869 | 20060346 | 1.8 | 76.25 | Neo-adjuvant (N) | 2019-12-17 | 2020-01-07 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100078921 |
| 20157870 | 20060347 | 1.69 | 61.7 | Neo-adjuvant (N) | null | 2019-04-12 | ECX | N | N | ECX | 101127907 |
| 20157872 | 20060348 | 1.83 | 88 | Neo-adjuvant (N) | 2018-11-26 | 2018-12-26 | ECX | N | N | ECX | 101180620 |
| 20157873 | 20060349 | 1.76 | 62 | Adjuvant (A) | 2017-07-06 | 2017-07-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100187148 |
| 20157875 | 20060350 | 1.82 | 55 | Neo-adjuvant (N) | 2018-03-24 | 2018-04-25 | ECX | N | N | ECX | 100967074 |
| 20157877 | 20060351 | 1.67 | 59.8 | null | 2016-11-04 | 2016-11-15 | ECX | N | N | ECX | 101400914 |
| 20157878 | 20060352 | 1.61 | 77.5 | Adjuvant (A) | 2018-12-05 | 2018-12-13 | ECX | 02 | N | ECX | 100596233 |
| 20157880 | 20060353 | 1.67 | 52.9 | Palliative (P) | 2018-09-30 | 2018-10-15 | ECX | N | N | ECX | 100484265 |
| 20157882 | 20060354 | 1.69 | 61 | Palliative (P) | 2016-03-17 | 2016-03-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101182382 |
| 20157884 | 20060355 | 1.58 | 61.8 | null | 2017-06-23 | 2017-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100131895 |
| 20157886 | 20060356 | 1.74 | 89.6 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-04 | ECX | 02 | N | ECX | 100040799 |
| 20157888 | 20060357 | 1.59 | 100 | Adjuvant (A) | null | 2017-12-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101165490 |
| 20157889 | 20060358 | 1.65 | 66.8 | Palliative (P) | 2017-09-09 | 2017-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101458467 |
| 20157890 | 20060359 | 1.67 | 48.7 | Curative (C) | 2016-07-12 | 2016-07-21 | ECX | N | N | ECX | 100897441 |
| 20157891 | 20060360 | 1.68 | 59.2 | null | 2018-01-25 | 2018-02-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101464664 |
| 20157892 | 20060361 | 1.73 | 63.8 | Neo-adjuvant (N) | 2018-02-03 | 2018-02-17 | ECX | N | N | ECX | 100817932 |
| 20157893 | 20060362 | 1.59 | 89.5 | Curative (C) | 2017-12-30 | 2018-02-05 | ECX | N | null | ECX | 100027619 |
| 20157894 | 20060363 | 1.8 | 64.4 | Neo-adjuvant (N) | 2017-10-30 | 2017-11-03 | ECX | N | N | ECX | 101601216 |
| 20157897 | 20060364 | 1.83 | 74.3 | Curative (C) | 2019-05-23 | 2019-05-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101084198 |
| 20157899 | 20060365 | 1.8 | 60.8 | Palliative (P) | 2018-01-23 | 2018-02-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100705567 |
| 20157900 | 20060366 | 1.79 | null | Curative (C) | null | 2016-05-28 | ECX | null | null | CAPECITABINE + GEMCITABINE | 100596668 |
| 20157901 | 20060367 | 1.81 | 57 | Palliative (P) | 2019-08-14 | 2019-08-28 | Gemcitabine + Capecitabine | N | Y | CAPECITABINE + GEMCITABINE | 100312710 |
| 20157902 | 20060368 | 1.66 | 62.6 | Adjuvant (A) | 2019-12-23 | 2020-01-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101806042 |
| 20157903 | 20060369 | 1.67 | 85.2 | Palliative (P) | 2016-12-06 | 2016-12-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101327461 |
| 20157904 | 20060370 | 1.84 | 53.6 | null | 2020-02-08 | 2020-02-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100393613 |
| 20157905 | 20060371 | 1.69 | 58.2 | Palliative (P) | 2019-06-25 | 2019-07-03 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100188290 |
| 20157906 | 20060372 | 1.68 | 73 | Adjuvant (A) | 2016-04-25 | 2016-05-05 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100879963 |
| 20157908 | 20060373 | 1.7 | 71.4 | Adjuvant (A) | 2018-09-11 | 2018-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101351467 |
| 20157913 | 20060374 | 1.76 | 48.9 | Palliative (P) | 2018-07-31 | 2018-07-31 | ECX | 02 | N | ECX | 100527349 |
| 20157914 | 20060375 | 1.66 | 83.6 | Palliative (P) | 2019-08-09 | 2019-08-09 | ECX | 2 | N | ECX | 100773851 |
| 20157915 | 20060376 | 1.77 | 66 | Palliative (P) | 2018-02-27 | 2018-03-02 | ECX | N | N | ECX | 100080099 |
| 20157916 | 20060377 | 1.65 | 74 | Curative (C) | 2018-11-17 | 2018-12-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100531347 |
| 20157917 | 20060378 | 1.63 | 75.4 | Palliative (P) | 2019-01-12 | 2019-01-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100001018 |